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To the Editor: Leishmaniasis is a
disease caused by parasites of the
genus  Leishmania. The infection is
transmitted to humans through the
bites of female sandflies and mani-
fests mainly in 3 forms: visceral, cuta-
neous, and mucocutaneous. Visceral
leishmaniasis or kala-azar, the often
fatal form of the disease, is caused by
species of the Leishmania donovani
complex. These parasites were
responsible for severe recent out-
breaks in Sudan and other countries
and are thought to originate in East
Africa (1–4).
In this report, we describe the suc-
cessful amplification of L. donovani
DNA in ancient Egyptian and
Christian Nubian mummies dating
back 4,000 years. Besides the first
proof for visceral leishmaniasis in
paleopathology, we provide evidence
that leishmaniasis was present in
Nubia in the early Christian period
and that the organism also infected
ancient Egyptians, probably because
of close trading contacts to Nubia,
during the Middle Kingdom. We ana-
lyzed 91 bone tissue samples from
ancient Egyptian mummies and skele-
tons and 70 bone marrow samples
from naturally mummified human
remains from Upper Nubia. The
Egyptian material derived from the
Pre- to Early Dynastic site of Abydos
(n = 7; 3500–2800 BC), a Middle
Kingdom tomb in Thebes West (42;
2050–1650  BC), and different tomb
complexes in Thebes West, which
were built and used between the
Middle and New Kingdom until the
Late Period (42; c. 2050–500 BC). The
Nubian samples were taken before the
flooding caused by the Aswan Dam
from 2 early Christian burial sites at
Kulubnarti, between the second and
third cataracts of the Nile River in
northern Sudan. One site was on an
island in the Nile and dated from 550
to 750 AD. The other was on the west-
ern bank of the Nile and was in use
from c.750 to 1500 AD. All samples
were tested for Leishmania spp. DNA
and further characterized by direct
sequencing.
In 4 of the 91 Egyptian and 9 of the
70 Nubian samples, a 120-bp frag-
ment of a conserved region of the
minicircle molecule of kinetoplastid
mitochondrial DNA of the parasite
(5,6) could be successfully amplified
and, with the first primer pair, unam-
biguously related to L. donovani
species after sequencing (Figure). The
positive samples from ancient Egypt
exclusively originated from the
Middle Kingdom tomb, while no
molecular evidence for ancient
Leishmania DNA was found in the
Pre- to Early Dynastic and the New
Kingdom to Late Period specimens.
In the Middle Kingdom, the
Egyptians extended trade relation-
ships and military expeditions to
Nubia, the modern Sudan, with partic-
ular interest in the gold resources of
the country and in obtaining slaves to
serve as servants or soldiers in the
pharaoh’s army. Today, the Sudan is
one of the highly endemic countries
for visceral leishmaniasis or kala-
azar, which is thought to have origi-
nated in East Africa and later spread
to the Indian subcontinent and the
New World (4). Therefore, the high
incidence of Leishmania DNA in the
Middle Kingdom samples (4 [9.5%]
of 42) and the lack of findings in ear-
lier or later time periods, may indicate
that leishmaniasis was introduced into
Egypt at this time. Leishmaniasis did
not likely become endemic in the
Egyptian Nile Valley because the dis-
ease is closely linked to its vector, the
phlebotomine sandfly, and the distri-
bution of Acacia-Balanites woodland
(7). That ancient Egyptians became
infected because of close trade con-
tacts and associated travel with Nubia
during the Middle Kingdom seems
more plausible. The high frequency of
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Leishmania DNA–positive samples in
the Nubian mummies (12.9%) sug-
gests that leishmaniasis was endemic
in Nubia during the Early Christian
period and, in light of the data on the
ancient Egyptian mummies, probably
already several thousand years before.
Taken together, our results support the
theory that Sudan could have been
indeed the original focus of visceral
leishmaniasis (4).
Our study shows a completely new
aspect of molecular paleopathology.
The detection of ancient pathogen
DNA is not only used to identify a
certain disease and gain information
on its frequency and evolutionary ori-
gin but also to trace back cultural con-
tacts and their role in the transmission
and spread of infectious diseases. 
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To the Editor: Approximately
3,000 cases of tickborne encephalitis
virus (TBEV) disease are registered
annually in Europe (1). In Italy,
indigenous TBEV infection cases
have been only sporadically recorded
from 1975 through 2001; in addition,
serologic investigations in popula-
tions at risk in northern Italy have
shown only a low prevalence of spe-
cific antibodies (0.6%–5%) (2,3). A
surveillance system for TBEV infec-
tions was started after autochthonous
TBEV was recognized in late summer
and fall 2003 in Friuli-Venezia Giulia
(FVG), a small region of northeastern
Italy with nearly 1 million inhabitants
(4). Surveillance is based on system-
atic microbiologic screening of all
patients referred to the emergency
departments of regional hospitals for
suspected community-acquired cen-
tral nervous system infections or fever
and headache with a history of tick
bite in the past 6 weeks. Screening for
TBEV was performed on sera or cere-
brospinal fluid (CSF) by enzyme
immunoassay (Enzygnost Anti-TBE
virus Ig, Dade Behring Marburg
GmbH, Marburg, Germany) and
repeated on convalescent-phase sera.
Demonstration of specific immuno-
globulin M (IgM) in serum or CSF in
the acute phase or >4-fold rise in
serum antibody titer in the convales-
cent phase was interpreted as an indi-
cator of recent TBEV infection. For
surveillance purposes, TBEV infec-
tion was defined when hemagglutina-
tion inhibition antibody test and neu-
tralization assay by a reference labo-
ratory confirmed ELISA results (5).
Data were collected at a regional ref-
erence center, where cases were clas-
sified as possible, probable, and con-
firmed, according to the new TBEV
case definition (6).
Figure. PCR amplification of a 120-bp fragment of kinetoplastid mitochondrial DNA of
Leishmania spp. in Egyptian and Nubian mummies. Lane 1, 50-bp ladder; lanes 2–8,
mummy samples; lanes 9,10, extraction controls; lane 11, PCR controls. Lane 6 provides
a positive amplification product of the expected size.